# China Registration Study in Patients With Skin Infections

> **NCT00772447** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 265 (actual)

## Conditions studied

- Skin Diseases
- Infectious

## Interventions

- **DRUG:** Daptomycin
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT00772447
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2015-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772447, "China Registration Study in Patients With Skin Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00772447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*